Emasan AG, the investment arm of the Sandoz family, has sold a significant stake in Swiss pharmaceutical giant Novartis ...

(Bloomberg) -- Novartis AG’s Sandoz family is poised to sell a roughly 1.2% stake in the Swiss pharmaceutical group.

The Ferrari deal is expected to be the largest of a clutch of block trades this week, including a Sfr2.6bn (€2.8bn) block in ...

European stocks advanced to a record high as a slate of corporate earnings boosted sentiment, while investors monitored ...

The European stock markets closed higher in Wednesday trading as The Stoxx Europe 600 rose 0.99%, Germany's DAX climbed 1.73%, the FTSE 100 in London gained 0.72%, France's CAC 40 advanced 1.15%, and ...

The Swiss army is set to spend CHF1.5 billion on new armaments. The 2025 Armed Forces Dispatch also plans to decommission the current Patrouille Suisse.

The investment company of the Sandoz family, Emasan AG, has divested a substantial portion of its holdings in Swiss pharmaceutical giant Novartis. Through an accelerated bookbuilding process, 26.5 ...

Montana, expressed his relief: “We can now proceed with this crucial work. We were rather worried, given the tight schedule.” Work is set to begin next week. The project includes renovating the timing ...

ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling ...

Novartis AG’s Sandoz family sold a roughly 1.2% stake in the Swiss pharmaceutical group for 2.6 billion Swiss francs ($2.9 ...